Manuscripts
Abstracts
August 7, 2022
Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data
World Conference on Lung Cancer 2022
Behera M et al
June 3, 2022
Natural language processing-optimized case selection for real world evidence studies
ASCO Annual Meeting 2022
Koskimaki J et al
June 3, 2022
Associations between biomarker testing and characteristics of patients with metastatic non-small cell lung cancer (mNSCLC): an analysis of CancerLinQ Discovery (CLQD) data
ASCO Annual Meeting 2022
Mileham KF et al
June 3, 2022
Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ASCO CancerLinQ Discovery data
ASCO Annual Meeting 2022
Behera M et al
June 3, 2022
The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, T1b, T1c), node-negative HER2+ breast cancer
ASCO Annual Meeting 2022
Johnson K et al
June 3, 2022
Diagnosed with advanced prostate cancer: A population-based cohort from national oncology practices
ASCO Annual Meeting 2022
Kim SP et al
June 3, 2022
Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis
ASCO Annual Meeting 2022
Moen EL et al
June 3, 2022
Impact of trial site selection on minority patient recruitment in prostate cancer trials
ASCO Annual Meeting 2022
Lagor C et al
June 3, 2022
Identifying genetic factors of response and resistance to CDK4/6 inhibitors in metastatic HR+/HER2- breast cancer using real-world data
ASCO Annual Meeting 2022
Agrawal S et al
